These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 86158)

  • 41. Treatment of recurrent herpes simplex labialis with oral acyclovir.
    Spruance SL; Stewart JC; Rowe NH; McKeough MB; Wenerstrom G; Freeman DJ
    J Infect Dis; 1990 Feb; 161(2):185-90. PubMed ID: 2153735
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit.
    Spruance SL; Crumpacker CS
    Am J Med; 1982 Jul; 73(1A):315-9. PubMed ID: 6285721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial.
    Hull C; McKeough M; Sebastian K; Kriesel J; Spruance S
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):263-7. PubMed ID: 19143902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arabinosyladenine monophosphate in genital herpes: a double-blind, placebo-controlled study.
    Hatcher VA; Friedman-Kien AE; Marcus EL; Klein RJ
    Antiviral Res; 1982 Oct; 2(5):283-90. PubMed ID: 6185089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Lysine therapy of recurrent herpes simplex labialis].
    Milman N; Jessen O; Scheibel J
    Ugeskr Laeger; 1979 Oct; 141(43):2960-2. PubMed ID: 392853
    [No Abstract]   [Full Text] [Related]  

  • 46. A clinical trial of topically applied 3 percent vidarabine against recurrent herpes labialis.
    Rowe NH; Brooks SL; Young SK; Spencer J; Petrick TJ; Buchanan RA; Drach JC; Shipman C
    Oral Surg Oral Med Oral Pathol; 1979 Feb; 47(2):142-7. PubMed ID: 218154
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol.
    Spruance SL; Schnipper LE; Overall JC; Kern ER; Wester B; Modlin J; Wenerstrom G; Burton C; Arndt KA; Chiu GL; Crumpacker CS
    J Infect Dis; 1982 Jul; 146(1):85-90. PubMed ID: 7045255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrent herpes labialis: current treatment perspectives.
    Sciubba JJ
    Compend Contin Educ Dent; 2002 Jul; 23(7 Suppl 2):9-12. PubMed ID: 12789981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis.
    Chen F; Xu H; Liu J; Cui Y; Luo X; Zhou Y; Chen Q; Jiang L
    J Oral Pathol Med; 2017 Sep; 46(8):561-568. PubMed ID: 27935123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir.
    Spruance SL; Crumpacker CS; Schnipper LE; Kern ER; Marlowe S; Arndt KA; Overall JC
    Antimicrob Agents Chemother; 1984 May; 25(5):553-5. PubMed ID: 6732224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections.
    Van Vloten WA; Swart RN; Pot F
    J Antimicrob Chemother; 1983 Sep; 12 Suppl B():89-93. PubMed ID: 6355055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Follow-up of interferon treatment of herpes simplex.
    Haverkos HW; Pazin GJ; Armstrong JA; Ho M
    N Engl J Med; 1980 Sep; 303(12):699-700. PubMed ID: 6157087
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical Inquiry: which drugs are most effective for recurrent herpes labialis?
    Tubridy E; Kelsberg G; St Anna L
    J Fam Pract; 2014 Feb; 63(2):104-5. PubMed ID: 24527475
    [No Abstract]   [Full Text] [Related]  

  • 54. Iontophoretic application of adenine arabinoside monophosphate for the treatment of herpes simplex virus type 2 skin infections in hairless mice.
    Kwon BS; Hill JM; Wiggins C; Tuggle C
    J Infect Dis; 1979 Dec; 140(6):1014. PubMed ID: 94335
    [No Abstract]   [Full Text] [Related]  

  • 55. Recurrent herpes simplex labialis: viral replication and clinical course.
    Rytel MW; Niebojewski RA; Aguilar-Torres FG; Russell TJ
    Am J Med Sci; 1978; 276(3):319-23. PubMed ID: 217269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Topical treatment of cutaneous herpes simplex virus infections.
    Spruance SL; Freeman DJ
    Antiviral Res; 1990 Dec; 14(6):305-21. PubMed ID: 2088209
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determining therapeutic efficacy in recurrent herpes labialis by lesion size analysis.
    Rodu B; Russell CM; Mattingly G
    Oral Surg Oral Med Oral Pathol; 1991 Aug; 72(2):178-83. PubMed ID: 1923396
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacology, tolerance, and antiviral activity of vidarabine monophosphate in humans.
    Whitley RJ; Tucker BC; Kinkel AW; Barton NH; Pass RF; Whelchel JD; Cobbs CG; Diethelm AG; Buchanan RA
    Antimicrob Agents Chemother; 1980 Nov; 18(5):709-15. PubMed ID: 6160811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of a topical herbal and mineral formulation (Dynamiclear) for the treatment of herpes simplex labialis in the community setting: study protocol for a randomised, double-blind placebo-controlled trial.
    Armour M; Semprini A; Ee C; MacCullagh L; Shortt N
    BMJ Open; 2020 Jan; 10(1):e031876. PubMed ID: 31932389
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase 3, randomized, double-blind, placebo-controlled study evaluating a single, patient-initiated dose of amenamevir for recurrent herpes labialis.
    Kawashima M; Watanabe D; Fujio K; Komazaki H
    J Dermatol; 2023 Mar; 50(3):311-318. PubMed ID: 36353762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.